Form 8-K - Current report:
SEC Accession No. 0001193125-24-238959
Filing Date
2024-10-17
Accepted
2024-10-17 17:10:59
Documents
56
Period of Report
2024-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818130d8k.htm   iXBRL 8-K 32315
2 EX-99.1 d818130dex991.htm EX-99.1 16855
3 EX-99.2 d818130dex992.htm EX-99.2 51981
7 GRAPHIC g818130ex99_2p10g1.jpg GRAPHIC 218610
8 GRAPHIC g818130ex99_2p11g1.jpg GRAPHIC 261817
9 GRAPHIC g818130ex99_2p12g1.jpg GRAPHIC 107005
10 GRAPHIC g818130ex99_2p13g1.jpg GRAPHIC 254422
11 GRAPHIC g818130ex99_2p14g1.jpg GRAPHIC 349343
12 GRAPHIC g818130ex99_2p15g1.jpg GRAPHIC 220956
13 GRAPHIC g818130ex99_2p16g1.jpg GRAPHIC 275678
14 GRAPHIC g818130ex99_2p17g1.jpg GRAPHIC 236605
15 GRAPHIC g818130ex99_2p18g1.jpg GRAPHIC 205192
16 GRAPHIC g818130ex99_2p19g1.jpg GRAPHIC 291060
17 GRAPHIC g818130ex99_2p1g1.jpg GRAPHIC 336637
18 GRAPHIC g818130ex99_2p20g1.jpg GRAPHIC 366476
19 GRAPHIC g818130ex99_2p21g1.jpg GRAPHIC 257981
20 GRAPHIC g818130ex99_2p22g1.jpg GRAPHIC 331423
21 GRAPHIC g818130ex99_2p23g1.jpg GRAPHIC 352658
22 GRAPHIC g818130ex99_2p24g1.jpg GRAPHIC 431884
23 GRAPHIC g818130ex99_2p25g1.jpg GRAPHIC 335101
24 GRAPHIC g818130ex99_2p26g1.jpg GRAPHIC 505979
25 GRAPHIC g818130ex99_2p27g1.jpg GRAPHIC 347727
26 GRAPHIC g818130ex99_2p28g1.jpg GRAPHIC 368554
27 GRAPHIC g818130ex99_2p29g1.jpg GRAPHIC 544904
28 GRAPHIC g818130ex99_2p2g1.jpg GRAPHIC 610965
29 GRAPHIC g818130ex99_2p30g1.jpg GRAPHIC 640775
30 GRAPHIC g818130ex99_2p31g1.jpg GRAPHIC 277159
31 GRAPHIC g818130ex99_2p32g1.jpg GRAPHIC 41248
32 GRAPHIC g818130ex99_2p33g1.jpg GRAPHIC 366093
33 GRAPHIC g818130ex99_2p34g1.jpg GRAPHIC 42287
34 GRAPHIC g818130ex99_2p35g1.jpg GRAPHIC 89778
35 GRAPHIC g818130ex99_2p36g1.jpg GRAPHIC 373598
36 GRAPHIC g818130ex99_2p37g1.jpg GRAPHIC 252180
37 GRAPHIC g818130ex99_2p38g1.jpg GRAPHIC 334683
38 GRAPHIC g818130ex99_2p39g1.jpg GRAPHIC 306986
39 GRAPHIC g818130ex99_2p3g1.jpg GRAPHIC 245716
40 GRAPHIC g818130ex99_2p40g1.jpg GRAPHIC 354899
41 GRAPHIC g818130ex99_2p41g1.jpg GRAPHIC 436067
42 GRAPHIC g818130ex99_2p4g1.jpg GRAPHIC 274351
43 GRAPHIC g818130ex99_2p5g1.jpg GRAPHIC 432541
44 GRAPHIC g818130ex99_2p6g1.jpg GRAPHIC 350543
45 GRAPHIC g818130ex99_2p7g1.jpg GRAPHIC 434031
46 GRAPHIC g818130ex99_2p8g1.jpg GRAPHIC 457549
47 GRAPHIC g818130ex99_2p9g1.jpg GRAPHIC 315284
  Complete submission text file 0001193125-24-238959.txt   18485368

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aura-20241017.xsd EX-101.SCH 2863
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20241017_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20241017_pre.xml EX-101.PRE 11267
58 EXTRACTED XBRL INSTANCE DOCUMENT d818130d8k_htm.xml XML 3624
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 241378322
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)